A detailed history of Schonfeld Strategic Advisors LLC transactions in Incyte Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 624,524 shares of INCY stock, worth $41 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
624,524
Previous 629,793 0.84%
Holding current value
$41 Million
Previous $35.9 Million 5.52%
% of portfolio
0.26%
Previous 0.26%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $269,667 - $335,898
-5,269 Reduced 0.84%
624,524 $37.9 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $18.6 Million - $22 Million
329,789 Added 109.93%
629,793 $35.9 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $14 Million - $17.3 Million
268,928 Added 865.39%
300,004 $18.8 Million
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $12.6 Million - $14.4 Million
-218,153 Reduced 87.53%
31,076 $1.8 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $15.2 Million - $18.8 Million
249,229 New
249,229 $15.5 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $1.01 Million - $1.27 Million
15,052 Added 171.67%
23,820 $1.91 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $580,266 - $726,516
8,768 New
8,768 $585,000
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $304,758 - $383,043
-4,605 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $950,357 - $1.15 Million
-14,395 Reduced 75.76%
4,605 $366,000
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $446,103 - $521,956
-7,043 Reduced 27.04%
19,000 $1.4 Million
Q3 2021

Nov 16, 2021

BUY
$68.67 - $84.02 $1.79 Million - $2.19 Million
26,043 New
26,043 $1.79 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $2.31 Million - $2.8 Million
-28,651 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$85.07 - $109.69 $2.44 Million - $3.14 Million
28,651 New
28,651 $3,000
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $503,162 - $738,872
-6,783 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $1.27 Million - $1.73 Million
-20,126 Reduced 74.79%
6,783 $497,000
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $469,062 - $614,713
-6,422 Reduced 19.27%
26,909 $2.35 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $2.43 Million - $2.88 Million
33,331 New
33,331 $2.47 Million
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $736,155 - $888,153
-10,013 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $5.12 Million - $7.11 Million
-80,587 Reduced 88.95%
10,013 $861,000
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $2.86 Million - $3.42 Million
48,900 Added 117.27%
90,600 $5.76 Million
Q3 2018

Nov 14, 2018

BUY
$61.75 - $74.23 $2.57 Million - $3.1 Million
41,700 New
41,700 $2.88 Million
Q2 2018

Aug 14, 2018

SELL
$60.85 - $83.98 $1.72 Million - $2.37 Million
-28,220 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$83.06 - $100.98 $2.12 Million - $2.58 Million
25,550 Added 956.93%
28,220 $2.35 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $511,773 - $637,802
-5,470 Reduced 67.2%
2,670 $253,000
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $888,481 - $1.13 Million
8,140
8,140 $951,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.